News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
754,604 Results
Type
Article (45926)
Company Profile (333)
Press Release (708321)
Multimedia
Podcasts (152)
Webinars (25)
Section
Business (213056)
Career Advice (2206)
Deals (37277)
Drug Delivery (144)
Drug Development (84707)
Employer Resources (178)
FDA (17046)
Job Trends (15699)
News (361648)
Policy (34677)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2663)
Accelerated approval (43)
Adcomms (34)
Allergies (169)
Alliances (52228)
ALS (201)
Alzheimer's disease (1785)
Antibody-drug conjugate (ADC) (397)
Approvals (17337)
Artificial intelligence (634)
Autoimmune disease (233)
Automation (50)
Bankruptcy (379)
Best Places to Work (11841)
BIOSECURE Act (22)
Biosimilars (214)
Biotechnology (194)
Bladder cancer (178)
Brain cancer (67)
Breast cancer (702)
Cancer (5461)
Cardiovascular disease (479)
Career advice (1865)
Career pathing (44)
CAR-T (311)
CDC (61)
Celiac Disease (2)
Cell therapy (834)
Cervical cancer (41)
Clinical research (72811)
Collaboration (1997)
Company closure (5)
Compensation (1300)
Complete response letters (83)
COVID-19 (2823)
CRISPR (106)
C-suite (1015)
Cystic fibrosis (154)
Data (7127)
Decentralized trials (3)
Denatured (43)
Depression (160)
Dermatology (58)
Diabetes (571)
Diagnostics (6945)
Digital health (52)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (309)
Drug pricing (229)
Drug shortages (35)
Duchenne muscular dystrophy (273)
Earnings (93270)
Editorial (66)
Employer branding (21)
Employer resources (158)
Events (122591)
Executive appointments (1069)
FDA (20520)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1650)
Gene editing (224)
Generative AI (58)
Gene therapy (691)
GLP-1 (1136)
Government (4926)
Grass and pollen (7)
Guidances (398)
Healthcare (19256)
HIV (75)
Huntington's disease (53)
IgA nephropathy (95)
Immunology and inflammation (306)
Immuno-oncology (87)
Indications (158)
Infectious disease (3150)
Inflammatory bowel disease (211)
Inflation Reduction Act (14)
Influenza (128)
Intellectual property (278)
Interviews (345)
IPO (17096)
IRA (58)
Job creations (4179)
Job search strategy (1563)
JPM (71)
Kidney cancer (19)
Labor market (93)
Layoffs (609)
Leadership (42)
Legal (8582)
Liver cancer (100)
Longevity (29)
Lung cancer (733)
Lymphoma (412)
Machine learning (53)
Management (62)
Manufacturing (965)
MASH (188)
Medical device (13987)
Medtech (14064)
Mergers & acquisitions (21347)
Metabolic disorders (1530)
mRNA (188)
Multiple sclerosis (179)
NASH (21)
Neurodegenerative disease (403)
Neuropsychiatric disorders (108)
Neuroscience (3233)
Neurotech (1)
NextGen: Class of 2026 (6740)
Non-profit (4601)
Now hiring (73)
Obesity (748)
Opinion (323)
Ovarian cancer (187)
Pain (247)
Pancreatic cancer (256)
Parkinson's disease (348)
Partnered (34)
Patents (566)
Patient recruitment (602)
Peanut (64)
People (61819)
Pharmaceutical (95)
Pharmacy benefit managers (36)
Phase 1 (22707)
Phase 2 (31972)
Phase 3 (23936)
Pipeline (7203)
Policy (335)
Postmarket research (2687)
Preclinical (9572)
Press Release (68)
Prostate cancer (280)
Psychedelics (52)
Radiopharmaceuticals (313)
Rare diseases (1051)
Real estate (6419)
Recruiting (72)
Regulatory (26250)
Reports (54)
Research institute (2479)
Resumes & cover letters (374)
Rett syndrome (32)
RNA editing (19)
RSV (93)
Schizophrenia (173)
Series A (275)
Series B (206)
Service/supplier (14)
Sickle cell disease (110)
Special edition (28)
Spinal muscular atrophy (171)
Sponsored (46)
Startups (3846)
State (2)
Stomach cancer (20)
Supply chain (124)
Tariffs (101)
The Weekly (106)
Vaccines (1112)
Venture capital (105)
Weight loss (507)
Women's health (111)
Worklife (20)
Date
Last 7 days (651)
Last 30 days (2590)
Last 365 days (30751)
2026 (8219)
2025 (31086)
2024 (36140)
2023 (40929)
2022 (52114)
2021 (56674)
2020 (55108)
2019 (47821)
2018 (36140)
2017 (33569)
2016 (33169)
2015 (39008)
2014 (32960)
2013 (28077)
2012 (30165)
2011 (30871)
2010 (28889)
Location
Africa (830)
Alabama (91)
Alaska (7)
Arizona (340)
Arkansas (15)
Asia (43401)
Australia (6893)
California (12371)
Canada (3546)
China (1291)
Colorado (528)
Connecticut (525)
Delaware (373)
Europe (93660)
Florida (1884)
Georgia (394)
Hawaii (3)
Idaho (62)
Illinois (978)
India (83)
Indiana (574)
Iowa (22)
Japan (502)
Kansas (130)
Kentucky (44)
Louisiana (40)
Maine (73)
Maryland (1504)
Massachusetts (8885)
Michigan (350)
Minnesota (681)
Mississippi (6)
Missouri (138)
Montana (33)
Nebraska (29)
Nevada (139)
New Hampshire (82)
New Jersey (3318)
New Mexico (31)
New York (3268)
North Carolina (1624)
North Dakota (8)
Northern California (6101)
Ohio (371)
Oklahoma (23)
Oregon (47)
Pennsylvania (2509)
Puerto Rico (27)
Rhode Island (50)
South America (1200)
South Carolina (77)
South Dakota (1)
Southern California (4857)
Tennessee (202)
Texas (1953)
United States (44045)
Utah (372)
Vermont (1)
Virginia (309)
Washington D.C. (81)
Washington State (993)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
754,604 Results for "kringle pharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Arna Pharma Inc. and Slate Run Pharmaceuticals to form a Joint Venture to Create Scaled-Up U.S. Specialty Pharmaceutical Platform
February 26, 2026
·
3 min read
Insights
ALS Advances Unite Patients and Pharma on Novel Targets, Biomarker Breakthroughs
In this episode of Denatured, you’ll be listening to Indu Navar, CEO and founder of EverythingALS and Dr. Olga Uspenskaya, chief medical officer at VectorY Therapeutics. We’ll be speaking about patient-pharma collaborations accelerating trials and hope, advances in ALS biology understanding and biomarker-driven endpoints.
February 26, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Press Releases
As mental health patients turn to AI chatbots, how can pharma lead the way?
A new report by Bryter released today reveals where pharma can lead as patients turn to (and question) AI tools for mental health.
February 5, 2026
·
1 min read
Press Releases
Nxera Pharma’s Partner Centessa Pharmaceuticals to be Acquired by Lilly
April 1, 2026
·
4 min read
Drug pricing
Despite MFN Deals, Drug Pricing Will Dog Pharma Into 2026
Only a handful of the top pharmas have signed Most Favored Nation drug pricing deals with the White House, while smaller biotechs continue to hang in limbo.
January 6, 2026
·
5 min read
·
Annalee Armstrong
Press Releases
Athira Pharma Announces Name Change to LeonaBio, Inc. with New Ticker “LONA”
January 9, 2026
·
9 min read
Vaccines
Uncertainty Looms Over Pharma’s Legal Strategy as States Challenge New Vaccine Schedule
The CDC’s changes threaten to cut vaccine sales for makers including Pfizer, Moderna, Merck and more, but a legal expert suspects affected manufacturers will stay on the sidelines rather than back a push to declare the revised schedule unlawful.
February 27, 2026
·
2 min read
·
Nick Paul Taylor
Editorial
Novo Returns to Pre-Wegovy Valuation as Lilly Makes History as First Ever $1T Pharma
Eli Lilly’s win in a head-to-head trial drove Novo Nordisk’s market cap to pre-Wegovy levels not long after the victor became the first pharma company to top a $1 trillion valuation. It seems one company can do no right, while the other can do no wrong.
February 24, 2026
·
3 min read
·
Jef Akst
Clinical research
Pharma R&D Spend Drops 3.6% as Pipeline Prioritizations Take Shape
Overall, the top 16 largest pharmaceutical companies spent $159 billion on research and development in 2025, compared to $165 billion the year prior. Here’s where all that cash went at companies like Johnson & Johnson, Amgen and Pfizer.
March 25, 2026
·
2 min read
·
Annalee Armstrong
Mergers & acquisitions
At JPM26, Policy and Politics Will Loom Large for Pharma as Biotech Sees the Sun
Pharmas will need to provide their latest stance on the Most Favored Nation drug pricing plans, while biotech finally gets a break after a few tough years.
January 9, 2026
·
4 min read
·
Annalee Armstrong
Previous
2 of 75,461
Next
